#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extraskeletal ossification Atopic keratoconjunctivitis Immune-mediated myasthenia gravis Exudative retinopathy Fibrous dysplasia of bone Paroxysmal nocturnal haemoglobinuria Skin angiosarcoma Brain injury Amyotrophic lateral sclerosis Hypergammaglobulinaemia benign monoclonal Oesophageal adenocarcinoma Cryoglobulinaemia Human papilloma virus immunisation Congenital absence of bile ducts Chronic myeloid leukaemia More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Life with Disease Skin angiosarcoma – Treatment Rett syndrome – Life with Disease Thrombotic thrombocytopenic purpura – Basic Information VEXAS syndrome – Treatment CADASIL – Diagnostics Marginal zone lymphoma Alternating hemiplegia of childhood – Life with Disease Biotinidase deficiency – Treatment Sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Antiemetics And Antinauseants Sonidegib Mannitol C1 Esterase Inhibitor (Human) Benfotiamine Verapamil Hydrochloride AZD4360 Mva-209-Fsp-B2 HYALURONIDASE Falbikitug Crofelemer Olive Oil, Refined POTASSIUM HYDROXIDE Cefixime Trihydrate [14C] DC-806 Gsk4527226 Risankizumab Isaralgagene Civaparvovec Tepotinib A/(H3N2)-LIKE VIRUS ANTIGEN More therapies…

    Learn about Your Condition

    Emphysema Open angle glaucoma Overweight Kaposi's sarcoma Toxic nodular goitre Habitual abortion Vulvovaginal discomfort Pseudomonas infection Meningococcal infection Gallbladder cancer Primary adrenal insufficiency Amyotrophic lateral sclerosis Thalassaemia alpha Skin papilloma Breast cancer recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Piperacillin/Tazobactam and Levofloxacin for Patients with COPD or Cystic Fibrosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Levofloxacin Hemihydrate
    • Piperacillin Monohydrate
    • Piperacillin
    Austria

  • Study on How Albumin Levels Affect Cefazolin in Heart Disease Patients with Low Albumin Undergoing Cardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefazolin
    • Human Plasma Proteins With Not Less Than 96% Albumin
    Austria

  • Study on the Effect of Metformin on Fertility in Women with Thyroid Cancer Treated with Radioactive Iodine

    Recruiting

    3 1 1
    Investigated Diseases:
    • Thyroid cancer
    Investigated Drugs:
    • Metformin Hydrochloride
    Poland

  • Study on Electrochemotherapy with Carboplatin and Bleomycin for Women with Relapsed Vulvar Cancer After Multiple Treatments

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Bleomycin Sulfate
    • Carboplatin
    Italy

  • Study on the Effectiveness and Safety of Bortezomib and Daratumumab for Patients with Primary Plasma Cell Leukemia

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    • Bortezomib
    • Daratumumab
    Greece

  • Study on the Effects of BT200 (Rondaptivon Pegol) for Patients with Type 2B von Willebrand Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Von Willebrand’s disease
    Investigated Drugs:
    • Rondaptivon Pegol
    Austria
Previous Page
1 … 296 297 298 299 300 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!